Insuline Pen Naalden 4mmAlso known as: Insulin pen needles 4 mm

Mechanism of Action

These insulin pen needles function as a delivery device component, allowing precise, controlled subcutaneous administration of peptides or insulin by providing a sterile, compatible interface between the device and biological tissue. They minimize tissue trauma due to their short 4 mm length and fine gauge.

Reported Research Benefits

• Used predominantly in research and laboratory environments for accurate dosing and administration of peptides such as BPC-157 via refillable insulin pens with a 3 ml reservoir. Not intended for human or medical treatment applications.

Dosing Protocol & Reconstitution

Research Notes

These needles support precise subcutaneous injections which are crucial for reproducible dosing in peptide research. Short length improves safety profile by reducing risk of deep tissue damage.

Research Summary

Insulin pen needles of 4 mm length have been extensively studied in clinical trials involving diabetic patients requiring insulin therapy. These short needles have been shown to provide effective and reliable subcutaneous insulin delivery with reduced pain and improved patient adherence compared to longer needles. Studies demonstrate comparable glycemic control outcomes between 4 mm needles and longer counterparts, with the added benefit of minimizing the risk of intramuscular injection, especially in lean individuals and children. The evidence is primarily high-quality clinical trial data, though some limitations include variability in patient technique and device compatibility.

Side Effects & Safety

Common side effects associated with insulin pen needles 4 mm include mild injection site reactions such as redness, bruising, or localized pain, which typically resolve quickly. Due to their short length and fine gauge, they reduce tissue trauma and the likelihood of hematoma formation compared to longer needles. There are no direct systemic side effects attributable to the needles themselves; however, improper use or needle reuse can increase the risk of infection or lipohypertrophy. No significant drug interactions are noted as these needles are delivery devices rather than active pharmaceuticals. They are safe for use in humans and are not on any banned substance lists such as WADA.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=Insulin+pen+needles+4+mm